Luye Pharma Group Ltd
Luye Pharma Group Ltd., an investment holding company, develops, produces, markets, and sells pharmaceutical products worldwide. The company offers Lipusu for ovarian and breast cancer; CMNa, a chemical sensitizer for cancer radiotherapy; Tiandida for ovarian or non-small cell lung cancer; Boyounuo, an injection for the treatment of various types of cancers and other solid tumors; and Xuezhikang, a lipid-regulating drug for the treatment of hypercholesterolaemia. It also provides Maitongna for cerebral edema swelling by trauma or surgery, and for venous reflux disorders; Beixi, an acarbose capsule for Type 2 diabetes; Rivastigmine Transdermal Patch for the treatment of Alzheimer's disease; Fentanyl Transdermal Patch for cancer pain; Buprenorphine Transdermal Patch for chronic pain; and Seroquel and Seroquel XR for the treatment of schizophrenia and manic episodes of bipolar affective disorders. In addition, the company offers Rykindo, an injection for the treatment of schizophrenia; Tiandixin used as an adjuvant therapy for malignant tumors, hydrothorax and ascites, and respiratory infections; Yitaida for acute promyelocytic leukemia and liver cancer; Lutingnuo, a glutathione injection for toxicity and injuries caused by ionizing radiation; and Beitangning, a pioglitazone hydrochloride capsule to control blood glucose. Further, it offers Nuosen for acute upper digestive tract hemorrhage; Sidinuo for osteoporosis; Glucosamine hydrochloride tablets for osteoarthritis; Oulai, a compound sodium aescinate gel for local swelling; Oukai for the treatment of soft tissue swelling and venous edema; and Fengshiye for patients who have pains in bones, joints, and limbs. The company distributes and sells pharmaceutical drugs; and manufactures and sells biopharmaceutical products. Luye Pharma Group Ltd. was founded in 1994 and is headquartered in Yantai, the People's Republic of China. Show More...
-
Website https://www.luye.cn
-
Sector Healthcare
-
Industry Drug Manufacturers-General
-
Last Quote 2.52 HKD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2009-12 2010-12 2011-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share CNY 0.25 0.28 0.31 0.63 0.2 0.23 0.27 0.3 0.4 0.46 0.46 Dividends CNY 0.03 0.06 0.09 0.12 0.12 Payout Ratio % * 25.5 20.5 21.8 25.9 Shares Mil 493.0 493.0 493.0 493.0 2.995 3.321 3.321 3.259 3.222 3.361 3.361 Book Value Per Share * HKD 0.58 1.9 2.05 2.32 2.5 2.96 3.07 Free Cash Flow Per Share * HKD 0.04 0.010 0.04 0.14 0.15 -0.37 Return on Assets % 9.54 8.13 7.09 9.17 12.72 11.45 10.97 9.83 9.21 7.97 7.97 Financial Leverage (Average) 1.54 1.62 1.92 1.91 1.25 1.25 1.43 1.59 2.25 2.09 2.09 Return on Equity % 13.66 12.88 12.62 17.55 18.14 14.27 14.75 14.87 17.88 17.24 17.24 Return on Invested Capital % 12.02 11.0 10.49 13.06 15.99 13.17 12.32 11.33 11.87 10.37 10.37 Interest Coverage 17.79 18.26 11.24 17.02 19.36 58.66 33.11 23.13 9.64 7.45 7.45 Current Ratio 2.27 1.95 1.04 1.27 3.97 4.85 2.22 1.72 1.06 1.69 1.69 Quick Ratio 1.93 1.71 0.89 0.94 3.52 4.28 1.81 1.46 0.79 1.26 1.26 Debt/Equity 0.03 0.010 0.11 0.45 0.45